| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Mar, 2025 |
| Sales | 0 | 1,570 | 1,260 | 0 | 0 |
| Sales Growth | -100.00% | +24.60% | unch | unch | unch |
| Net Income | -110,780 | -11,970 | -26,480 | -230 | 0 |
| Net Income Growth | -825.48% | +54.80% | -11,413.04% | unch | unch |
Humacyte Inc (HUMA)
3.32 +0.14 (+4.40%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 3.21 -0.11 (-3.31%) 03/21/25
for Fri, Mar 21st, 2025
Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.
Fiscal Year End Date: 12/31